Ondansetron Teva (Ondansetron Hydrochloride Dihydrate)

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Teva, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It treats and helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron Teva is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: helps control nausea during and after radiotherapy. - Post‑operative nausea and vomiting: prevents vomiting in the immediate postoperative period. - Pregnancy‑associated nausea (when prescribed): may be used under specialist supervision to alleviate severe nausea. - Hyper‑emesis gravidarum: provides symptom relief in severe cases when other treatments are insufficient.

Side effects of ondansetron are generally mild and dose‑dependent.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement difficulty. - Diarrhoea: loose stools in a minority of patients. - Fatigue: feeling of tiredness or reduced energy. - Dizziness: transient light‑headed sensations.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation, especially with IV use. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: rare when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes in susceptible individuals. - Vision changes: blurred vision or visual disturbances.

When using Ondansetron Teva, consider the following precautions to ensure safe and effective therapy.

- Cardiac monitoring: assess baseline ECG in patients with known heart rhythm disorders. - Electrolyte balance: correct hypokalemia or hypomagnesemia before initiation. - Concomitant serotonergic drugs: evaluate risk of serotonin syndrome. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Renal or hepatic impairment: dose adjustment may be required based on clinical judgement. - Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Ondansetron may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Apatinol (Apixapine?) - Monodun   g  )   g   g  -  

Moderate   g  t  g  t  g  t  g 

g  t  g  -  g  -  t  -  g  -  -  g  -  t  -  g  -  t  g  -  -  g  -  -  t  -  g  -  -  g  -  -  t g  -  t  -  -  g  -  -  g  -  -  g de  t -   g -  -  g de -  -  g de -  t -  -  g de -  t - ",